相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Using simulation studies to evaluate statistical methods
Tim P. Morris et al.
STATISTICS IN MEDICINE (2019)
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
Everardo D. Saad et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
Everardo D. Saad et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Extrapolation of Survival Curves from Cancer Trials Using External Information
Patricia Guyot et al.
MEDICAL DECISION MAKING (2017)
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods
Christopher Jackson et al.
MEDICAL DECISION MAKING (2017)
MULTIVARIATE NETWORK META-ANALYSIS OF SURVIVAL FUNCTION PARAMETERS
S. Cope et al.
VALUE IN HEALTH (2017)
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models
Suzanne C. Freeman et al.
RESEARCH SYNTHESIS METHODS (2017)
Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us
Donna Spiegelman et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
Immuno-oncology combinations: raising the tail of the survival curve
Sarnuel J. Harris et al.
CANCER BIOLOGY & MEDICINE (2016)
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
Wilfried Ernst Erich Eberhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data
Yinghui Wei et al.
STATISTICS IN MEDICINE (2015)
Survival Analysis and Extrapolation Modeling of Time-to-Event Clinical Trial Data for Economic Evaluation: An Alternative Approach
Adrian Bagust et al.
MEDICAL DECISION MAKING (2014)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
Sofia Dias et al.
MEDICAL DECISION MAKING (2013)
Evidence Synthesis for Decision Making 4: Inconsistency in Networks of Evidence Based on Randomized Controlled Trials
Sofia Dias et al.
MEDICAL DECISION MAKING (2013)
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
A Phase 3 Study of Induction Treatment With Concurrent Chemoradiotherapy Versus Chemotherapy Before Surgery in Patients With Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903)
Nobuyuki Katakami et al.
CANCER (2012)
Two-stage meta-analysis of survival data from individual participants using percentile ratios
Jessica K. Barrett et al.
STATISTICS IN MEDICINE (2012)
Network meta-analysis of survival data with fractional polynomials
Jeroen P. Jansen
BMC MEDICAL RESEARCH METHODOLOGY (2011)
The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
Patrick Royston et al.
STATISTICS IN MEDICINE (2011)
Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness
Patricia Guyot et al.
VALUE IN HEALTH (2011)
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
Nicolas Girard et al.
LUNG CANCER (2010)
One-stage parametric meta-analysis of time-to-event outcomes
F. Siannis et al.
STATISTICS IN MEDICINE (2010)
Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies
N. J. Welton et al.
RESEARCH SYNTHESIS METHODS (2010)
Network meta-analysis of parametric survival curves
Mario J. N. M. Ouwens et al.
RESEARCH SYNTHESIS METHODS (2010)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Meta-analysis of mixed treatment comparisons at multiple follow-up times
G. Lu et al.
STATISTICS IN MEDICINE (2007)
Conditional survival in head and neck squamous cell carcinoma - Results from the SEER dataset 1973-1998
Clifton D. Fuller et al.
CANCER (2007)
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan P. van Meerbeeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Bayesian measures of model complexity and fit
DJ Spiegelhalter et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2002)
分享论文
